Baillie Gifford - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 147 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$14,558
-1.6%
360
+13.2%
0.00%
Q4 2022$14,793
-7.5%
3180.0%0.00%
Q3 2022$16,000
+6.7%
3180.0%0.00%
Q2 2022$15,000
-34.8%
3180.0%0.00%
Q1 2022$23,0003180.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 624,768$29,533,0009.76%
Fairmount Funds Management LLC 469,264$22,182,0005.08%
Foresite Capital Opportunity Management V, LLC 22,750$1,075,0002.71%
ARMISTICE CAPITAL, LLC 2,070,000$97,849,0001.71%
Paradigm Biocapital Advisors LP 148,216$7,006,0001.40%
Foresite Capital Management V, LLC 42,250$1,997,0001.40%
RA Capital Management 896,724$42,389,0001.13%
TANG CAPITAL MANAGEMENT LLC 137,700$6,509,0000.99%
Soleus Capital Management, L.P. 100,000$4,727,0000.74%
ACUTA CAPITAL PARTNERS, LLC 27,500$1,300,0000.72%
View complete list of ENANTA PHARMACEUTICALS INC shareholders